• Retrosense Therapeutics LLC, of Ann Arbor, Mich., received a grant of $250,000 from the Foundation Fighting Blindness to support development of its investigational gene therapy product based on genes from blue-green algae. The foundation may invest additional funds upon achievement of certain milestones in the research. The company anticipates beginning clinical trials in two to four years.